[Corrigendum] MicroRNA‑100 functions as a tumor suppressor in cervical cancer via downregulating the SATB1 expression and regulating AKT/mTOR signaling pathway and epithelial‑to‑mesenchymal transition
Affiliations: Department of Gynaecology, The Second Hospital of Shandong University, jinan, Shandong 250033, P.R. China, Department of Obstetrics and Gynecology, Zhangqiu Maternity and Child Care Hospital, jinan, Shandong 250200, P.R. China, Department of Imaging, People's Hospital of Rizhao, Rizhao, Shandong 276800, P.R. China, Ward Department, The People's Hospital of Zhangqiu Area, jinan, Shandong 250200, P.R. China, Department of Radiology, The People's Hospital of Zhangqiu Area, jinan, Shandong 250200, P.R. China, Department of Interventional Medicine, The Second Hospital of Shandong University, jinan, Shandong 250033, P.R. China
- Published online on: August 17, 2021 https://doi.org/10.3892/ol.2021.13002
- Article Number: 741
Copyright : © Huang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
This article is mentioned in:
Oncol Lett 20: [Related article:] 1336-1344, 2020; DOI: 10.3892/ol.2020.11686
Subsequently to the publication of the above article, an interested reader drew to the authors’ attention that a section of the data shown in Fig. 1C (Transwell assay data for HeLa cells), the “miR-100 inhibitor” panel appeared to be overlapping with the “miR-100 inhibitor” panel featured in Fig. 1D (showing the Transwell assay data for Ca-Ski cells).
The authors have checked their original data, and realized that the incorrect data were inadvertently selected for the “miR-100 inhibitor” panel in Fig. 1D. A corrected version of Fig. 1, including the correct data for Fig. 1D, is shown below. The authors are grateful to the Editor of Oncology Letters for granting them the opportunity to publish this corrigendum, and regret any inconvenience caused to the readership of the Journal.